Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Submitted by
admin
on January 23, 2018 - 2:48pm
Source:
Endpoints
News Tags:
pancreatic cancer
ChemoCentryx
CCX872
Headline:
Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Do Not Allow Advertisers to Use My Personal information
